Goldman Sachs just refreshed its lists of top global stock picks, adding some and removing others. The investment bank's "Conviction List - Directors' Cut" aims to offer investors a "curated and active" list of 15 to 25 buy-rated stocks. The stocks are selected by a subcommittee designated by the bank's Investment Review Committee for each region.
Samsung Biologics Goldman likes South Korean biotechnology company Samsung Biologics, which it says is "set to capitalize on growing demand for biologics CDMOs via its build-out of world-leading capacity." Other merits of the company include its "competitive pricing strategy," Goldman analyst Ziyi Chen wrote in a May 2 note on the bank's Asia-Pacific list.
Italia Ultime Notizie, Italia Notizie
Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.
Fonte: CNBC - 🏆 12. / 72 Leggi di più »
Fonte: CNBC - 🏆 12. / 72 Leggi di più »
Fonte: CNBC - 🏆 12. / 72 Leggi di più »